Loading...

Home
ETF
XERS

XERS

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

XERS News

Xeris Biopharma Agrees to Retire $23M Convertible Notes

Jun 11 2026seekingalpha

Xeris Biopharma Reduces Debt by $23 Million

Jun 11 2026Newsfilter

Market Sentiment Shift Impacts Multiple Stocks

Jun 10 2026CNBC

Xeris Biopharma Reports Strong Q1 2026 Earnings Growth

May 07 2026seekingalpha

Xeris Pharmaceuticals Q1 Earnings Beat Expectations

May 07 2026seekingalpha

Xeris Pharmaceuticals to Announce Q1 Earnings on May 7

May 06 2026seekingalpha

Xeris Biopharma Projects 2026 Revenue Guidance Above Consensus

Mar 02 2026seekingalpha

Xeris Biopharma Reports Record Revenue Growth and Profitability in Q4 2025

Mar 02 2026seekingalpha

Xeris Pharmaceuticals Q4 Earnings Beat Expectations

Mar 02 2026seekingalpha

Wall Street's First Trading Day of March Outlook

Mar 01 2026CNBC

Xeris Biopharma Shares Drop Amid Patent Infringement Lawsuit

Feb 27 2026Benzinga

Xeris Pharmaceuticals to Announce Q4 Earnings on March 2

Feb 27 2026seekingalpha

Xeris Biopharma Files Patent Infringement Lawsuit Against Generic Competitors

Feb 26 2026Businesswire

Xeris Biopharma to Release Q4 and Full Year 2025 Financial Results

Feb 17 2026Businesswire

Xeris Biopharma to Release 2025 Financial Results

Feb 17 2026Newsfilter

Analyst Target Prices Indicate Potential for Pharmaceuticals ETF

Jan 29 2026NASDAQ.COM